PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

Condition:   Breast Cancer Interventions:   Drug: Leuprorelin acetate;   Drug: Letrozole;   Genetic: MammaPrint Sponsor:   Seoul National University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials